A detailed history of American Financial Group Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, American Financial Group Inc holds 205,000 shares of CGTX stock, worth $94,300. This represents 0.04% of its overall portfolio holdings.

Number of Shares
205,000
Previous 205,000 -0.0%
Holding current value
$94,300
Previous $340,000 71.76%
% of portfolio
0.04%
Previous 0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

BUY
$5.1 - $12.98 $1.05 Million - $2.66 Million
205,000 New
205,000 $1.3 Million

Others Institutions Holding CGTX

About COGNITION THERAPEUTICS INC


  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $10.4M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track American Financial Group Inc Portfolio

Follow American Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Financial Group Inc with notifications on news.